Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Journal of Virology
|
February 4, 2025
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
The New England Journal of Medicine
|
June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
Julie Boucau, Caitlin Marino, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
Julie Boucau, Caitlin Marino, James Regan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 14, 2019
CD82 controls CpG-dependent TLR9 signaling
Nida S Khan, Daniel P Lukason, Marianela Feliu, et al.
Journal of Dairy Science
|
July 22, 2020
Letter to the Editor: Silage manuscripts in the Journal of Dairy Science
A T Adesogan, H Auerbach, T F Bernardes, et al.
JAMA Network Open
|
September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral Treatment
Trevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S Seaman, Mark J Siedner, Julie Boucau, et al.
JCI Insight
|
October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
Michael S Seaman, Mark J Siedner, Julie Boucau, et al.
Research Square
|
December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients
Sara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Journal of Virology
|
February 4, 2025
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
The New England Journal of Medicine
|
June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
Julie Boucau, Caitlin Marino, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
Julie Boucau, Caitlin Marino, James Regan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 14, 2019
CD82 controls CpG-dependent TLR9 signaling
Nida S Khan, Daniel P Lukason, Marianela Feliu, et al.
Journal of Dairy Science
|
July 22, 2020
Letter to the Editor: Silage manuscripts in the Journal of Dairy Science
A T Adesogan, H Auerbach, T F Bernardes, et al.
JAMA Network Open
|
September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral Treatment
Trevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S Seaman, Mark J Siedner, Julie Boucau, et al.
JCI Insight
|
October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
Michael S Seaman, Mark J Siedner, Julie Boucau, et al.
Research Square
|
December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients
Sara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Page
of 12